{"version":"1.0","type":"link","title":"Saredutant - Newikis","description":"Saredutant (SR-48,968) is a drug that acts as a NK2 receptor antagonist. It was under development by Sanofi-Aventis as a novel antidepressant and anxiolytic and made it to phase III clinical trials. However, in May 2009, Sanofi-Aventis published its quarterly results and announced the cessation of…","provider_name":"Newikis","provider_url":"https://newikis.com","cache_age":86400,"thumbnail_url":"https://thumb.wikimedia.org/wikipedia/commons/thumb/b/b5/Saredutant.svg/1280px-Saredutant.svg.png","thumbnail_width":1280,"thumbnail_height":876}